| Survivors (n= 37) | Non-survivors (n= 24) | P value |
---|---|---|---|
Hemodynamic parameters | Â | Â | Â |
   Heart rate, beats/min | 103 (90-114) | 120 (90-140) | 0.004 |
   Mean arterial pressure, mm Hg | 76 (74-83) | 74 (70-82) | 0.189 |
   Central venous pressure, mm Hg | 16 (12-17) | 14 (11-19) | 0.911 |
   Dopamine, n (%) | 17 (46) | 10 (42) |  |
Dose, μg/kg/min | 5.0 (4.0-10.0) | 6.0 (4.5-10.0) | 0.836 |
   Norepinephrine, n (%) | 30 (81) | 19 (79) |  |
Dose, μg/kg/min | 0.3 (0.2-0.5) | 0.6 (0.2-1.0) | 0.007 |
   Balance on day 0, ml/24 hours | 1,180 (445-2,140) | 1,850 (15-3,004) | 0.640 |
Echocardiographic data | Â | Â | Â |
   Systolic parameters |  |  |  |
LVEDV, ml | 72 (54-98) | 63 (56-78) | 0.110 |
LVESV, ml | 30 (20-52) | 26 (19-34) | 0.169 |
LVEF biplane, % | 56 (36-65) | 63 (52-66) | 0.111 |
LVEF biplane < 50%, n (%) | 12 (33) | 4 (17) | 0.234 |
Sa, cm/sec | 7.8 (5.5-9.0) | 11.0 (9.1-12.5) | < 0.0001 |
Sa > 9 cm/s, n (%) | 6 (17) | 18 (75) | < 0.0001 |
   Diastolic parameters |  |  |  |
E/A | 0.9 (0.7-1.4) | 0.7 (0.6-1.2) | 0.171 |
Ea, cm/sec | 8.3 (5.8-10.0) | 7.0 (6.0-11.0) | 0.634 |
Ea < 8 cm/sec, n (%) | 15 (42) | 12 (52) | 0.429 |
E/Ea | 11.1 (8.5-14.6) | 11.1 (6.6-14.1) | 0.206 |